ArticleOncotarget2018
AP-1 confers resistance to anti-cancer therapy by activating XIAP.
Yuan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleOncotarget2018
Yuan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.